Shots: Abbott’s SARS-CoV-2 IgG lab-based serology blood test is the fourth COVID-19 detection test to receive the FDA’ EUA based on Alinity i platforms, which is a next-generation immunoassay instrument […]readmore
Tags : Abbott
WuXi Biologics and Aravive Collaborate to Develop Novel High-Affinity Bispecific Antibodies for Cancer and Fibrosis Published: Apr 30, 2020 | Tags: WuXi Biologics, Aravive, Collaborate, Develop, Novel, High-Affinity Bispecific Antibodies, Cancer, […]readmore
COVID-19
DigiHealth
Abbott’s Freestyle Libre System Receives Health Canada Authorization Under Interim
Shots:Shots: Health Canada has authorized the use of Abbott’s FreeStyle Libre system in the hospital amid COVID-19. The authorization will allow HCPs to remotely monitor patients’ glucose status to minimize […]readmore
The global biopharma companies are developing novel therapies & devices which is, in turn, enhancing their portfolio and encouraging them in this undergoing competition to stay in the topmost position […]readmore
1. Sinovac Initiates the P-I Clinical Study for Vaccine Candidate Against COVID-19 Published: Apr 17, 2020 | Tags: Sinovac, Initiates, P-I, Clinical Study, Vaccine Candidate, Against, COVID-19 2. 1Health.io Launches Self-Collection […]readmore
Shots: Abbott has launched its third COVID-19 test, a lab-based serology blood test to detect AB, IgG that identifies a person with COVID-19. The Ab testing will provide more understanding […]readmore
Amgen Signs a Partnership with Adaptive Biotechnologies to Develop for COVID-19 Published: Apr 09, 2020 | Tags: Amgen, Adaptive Biotechnologies, Develop, Abs, COVID-19 2. Samsung Biologics Signs an Agreement with […]readmore
Shots: The CE Mark approval is based on TRILUMINATE study with positive six-month data assessing edge-to-edge repair technique using TriClip and resulted in reduced severity of TR with improvement in […]readmore
1. Sorrento Initiates the Next Phase of its Collaboration with Celularity Published: Apr 02, 2020 | Tags: Sorrento, Initiates, Next Phase, Collaboration, Celularity 2. Celltrion Enters the Next Phase of […]readmore
Shots: Abbott has received the US FDA’s EUA for its molecular point-of-care test to detect novel COVID-19 and runs on its ID NOW platform, delivering positive results in just five […]readmore